Percutaneous medicine administration kit, medicated, single-use

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Janssen-Cilag Pty Ltd

Classe:

Class IIa

Prodotto da:

Cilag AG Hochstrasse 201, SCHAFFHAUSEN, CH8200 Switzerland

Area terapeutica:

45156 - Medicine administration kit, percutaneous, medicated, single-use

Indicazioni terapeutiche:

A kit for the intramuscular administration of the medicine Risperdal Consta. Kit includes the medicine Risperdal Consta; a prefilled syringe containing a dilutent; one needle-free vial access device; two needles with needle protection devices (21g for deltoid administration and a 20g for gluteal administration).

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2006-04-07